Glenmark Pharmaceuticals has informed that the board of directors of the company at its meeting held on August 02, 2012, allotted 33,500 shares to the employees of the company on exercise of options granted to them pursuant to ESOS 2003.
The above information is a part of company's filings submitted to BSE.